Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Therapeutic antibodies for brain disorders
Steven M. Paul
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic antibodies for brain disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Receptor
100%
Brain Disease
100%
Transcytosis
100%
Alzheimer's Disease
50%
Monoclonal Antibody
50%
Blood Brain Barrier
50%
Translational Medicine
50%
Secretase
50%
Human Monoclonal Antibody
50%
Transferrin Receptor
50%
Diseases
50%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Brain Disease
100%
Transcytosis
100%
Alzheimer's Disease
50%
Monoclonal Antibody
50%
Secretase
50%
Human Monoclonal Antibody
50%
Transferrin Receptor
50%
Blood-Brain Barrier
50%
Diseases
50%
Keyphrases
Therapeutic Antibody
100%
Brain Disorders
100%
β-site APP-cleaving Enzyme 1 (BACE1)
100%
Receptor-mediated Transcytosis
40%
Alzheimer's Disease
20%
Monoclonal Antibody
20%
Blood-brain Barrier
20%
Antibody Targeting
20%
Low Affinity
20%
Disease-modifying Therapy
20%
Potential Diseases
20%
Translational Medicine
20%
Secretase
20%
BACE1 Inhibitor
20%
Monospecific Antibody
20%
Brain Uptake
20%
Transferrin Receptor 1 (TfR1)
20%
Bispecific Monoclonal Antibody
20%
Biochemistry, Genetics and Molecular Biology
Therapeutic Antibodies
100%
Transcytosis
100%
Enzyme
50%
Monoclonal Antibody
50%
Blood Brain Barrier
50%
Secretase
50%
Transferrin Receptor
50%
Bispecific Monoclonal Antibody
50%